All In Biotech

Drug Trial Radar · NCT05371613

A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)

A Phase 2/3, Multicenter, Double-Blind, Randomized Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic or Non-Neuronopathic Mucopolysaccharidosis Type II

Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

65

Actual

Start

Jul 21, 2022

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Denali Therapeutics Inc.Industry
Sponsor type
Industry
First posted
May 12, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years, up to 25 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2/3, multiregional, two-arm, double-blind, randomized, active (standard-of-care)-controlled study of the efficacy and safety of tividenofusp alfa (DNL310), an investigational central nervous system (CNS)-penetrant enzyme-replacement therapy (ERT) for mucopolysaccharidosis type II (MPS II). Participants may also qualify to enter an open-label treatment phase with DNL310 or idursulfase based on pre-specified criteria.

Conditions

  • Mucopolysaccharidosis II

Interventions

  • tividenofusp alfaDrug

    Intravenous repeating dose

  • idursulfaseDrug

    Intravenous repeating dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ratio to baseline in cerebrospinal fluid (CSF) heparan sulfate (HS) concentration (Cohort A)Time frame: 24 weeks
  2. Change from baseline in the Vineland Adaptive Behavior Scale, Third Edition (Vineland-3)(Cohort A)Time frame: 96 weeks

Locations

30 sites in 14 countries. Site status is shown where the registry gives one.

  • UCSF Benioff Children's Hospital Oakland

    Oakland, California

  • Ann and Robert H Lurie Children's Hospital of Chicago

    Chicago, Illinois

  • Hackensack University Medical Center

    Hackensack, New Jersey

  • UNC Children's Research Institute

    Chapel Hill, North Carolina

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • The University of Texas Medical School at Houston

    Houston, Texas

  • University of Utah, PPDS

    Salt Lake City, Utah

  • Sanatorio Mater Dei

    Buenos Aires, Argentina

  • UZ Antwerpen

    Antwerp, Antwerpen, Belgium

  • Universitair Ziekenhuis Brussel

    Jette, Brussels Capital, Belgium

  • Hospital de Clínicas de Porto Alegre (HCPA) - PPDS

    Porto Alegre, Brazil

  • University of Alberta - Faculty of Medicine & Dentistry

    Edmonton, Alberta, Canada

  • Hospital for Sick Children

    Toronto, Ontario, Canada

  • McGill University Health Center

    Montreal, Quebec, Canada

  • Vseobecna Fakultni Nemocnice V Praze

    Prague, Czechia

  • Hôpital Jeanne de Flandre

    Lille, France

  • Medizinische Universität Lausitz - Carl Thiem

    Cottbus, Germany

  • SphinCS

    Höchheim, Hochheim, Germany

  • Azienda Sanitaria Universitaria Friuli Centrale - PO Universitario Santa Maria della Misericordia

    Udine, Italy

  • Erasmus Medical Center - Sophia Children's Hospital

    Rotterdam, Rotterdam, Netherlands

  • Hospital Universitario Vall d'Hebron

    Barcelona, Barcelona, Spain

  • Hospital Infantil Universitario Niño Jesus

    Madrid, Madrid, Spain

  • Drottning Silvias Barn Och Ungdomssjukhus

    Gothenburg, Sweden

  • Cukurova University Medical Faculty Balcali Hospital

    Adana, Turkey (Türkiye)

  • Gazi Universitesi Tip Fakultesi

    Çankaya, Turkey (Türkiye)

  • Birmingham Women's and Children's NHS Foundation Trust

    Birmingham, United Kingdom

  • Royal Free Hospital

    London, United Kingdom

  • Salford Royal Hospital

    Salford, United Kingdom

  • Great Ormond Street Hospital for Children

    London, London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.